1. Home
  2. BCBP vs CRVS Comparison

BCBP vs CRVS Comparison

Compare BCBP & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BCB Bancorp Inc. (NJ)

BCBP

BCB Bancorp Inc. (NJ)

HOLD

Current Price

$10.02

Market Cap

139.1M

Sector

Finance

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$15.75

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCBP
CRVS
Founded
2000
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
139.1M
1.2B
IPO Year
2005
2016

Fundamental Metrics

Financial Performance
Metric
BCBP
CRVS
Price
$10.02
$15.75
Analyst Decision
Hold
Strong Buy
Analyst Count
2
6
Target Price
$10.00
$30.17
AVG Volume (30 Days)
90.3K
1.1M
Earning Date
04-21-2026
05-07-2026
Dividend Yield
3.25%
N/A
EPS Growth
N/A
48.04
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$85.26
N/A
Revenue Next Year
$6.14
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.31
$3.17
52 Week High
$10.25
$26.95

Technical Indicators

Market Signals
Indicator
BCBP
CRVS
Relative Strength Index (RSI) 72.69 50.71
Support Level $7.55 $14.38
Resistance Level N/A $18.73
Average True Range (ATR) 0.30 1.12
MACD 0.03 0.28
Stochastic Oscillator 80.17 28.20

Price Performance

Historical Comparison
BCBP
CRVS

About BCBP BCB Bancorp Inc. (NJ)

BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: